Evercore ISI Group Rates Welltower (WELL) buy, $236 Price Target

Evercore ISI reaffirms its buy stance on Welltower Inc. with a $236 price target, a 3.98% upside from the current price.

By TradeTexts Research Desk · Published Jul 1, 2026, 10:01 AM EDT · Updated Jul 1, 2026, 3:01 PM EDT

Reviewed by automated data checks against the source data. How we make and check alerts

Evercore ISI Group rated Welltower Inc. ($WELL) "buy" with a $236 price target on July 1, 2026.

Since the rating, $WELL is up 1.6% after 1 week, up 1.9% after 1 month and up 2.4% to date (from the $229.32 close on Jul 1, 2026).

WELL Welltower Inc.

$234.85 +26.98% year to date

Daily close · Oct 16, 2026

Key Points

Evercore ISI Group reiterated its buy rating on Welltower Inc. (WELL) with a price target of $236.
Evercore ISI Group's $236 price target implies 3.98% upside from Welltower Inc.'s ($WELL) current $226.97 share price.
Welltower Inc. shares traded near $226.97 on Wednesday, with a market cap of about $160.2 billion.
Analyst ratings remain strong with multiple firms maintaining buy ratings and price targets above $230.

Get $WELL trade alerts by text

We text you when insiders, Congress or big funds trade $WELL. Free.

Not investment advice. TradeTexts is not a registered investment adviser, and this automated Welltower Inc. alert may contain errors. Disclosures

Evercore ISI Group has reiterated its buy rating on Welltower Inc. (NYSE: WELL), setting a price target of $236. The reaffirmation was made by analyst Steve Sakwa on July 1, 2026. Shares of Welltower traded near $226.97 on Wednesday.

Analyst rating track record

Evercore ISI Group vs. the S&P 500

YTD return +16.55% hypothetical

All-time return +29.91% S&P 500 +28.47%

vs. S&P 500 +1.44% ahead of the index

Hypothetical returns from Evercore ISI Group's disclosed trades, not real profit or advice. How we model this.

Welltower Inc. Stock Down 0.8%

Shares of NYSE:WELL traded around $226.97 on Wednesday. Welltower Inc., with a market capitalization of approximately $160.2 billion, has a P/E ratio of 109.6 and a forward P/E of 67.6. The stock has a 52-week low of $148.97 and a high of $230.07. Its 50-day moving average is $212.29, and the 200-day moving average is $196.35. Welltower maintains a beta of 0.78, indicating lower volatility compared to the market.

12-month forecast

$WELL price target

Welltower Inc. daily closes and this analyst's $236 target. Not advice.

Recent Earnings

Welltower reported revenue of about $11.77 billion, showing a growth of 38.3%. The company's net margin stands at 11.96%, with a return on equity of 3.67%. Earnings per share were $2.07. Investors can look forward to the next earnings report scheduled for July 27, 2026.

Dividend

Welltower offers an annual dividend rate of $2.96, resulting in a yield of 1.3%. The dividend payout ratio is 139.61%, reflecting a significant return to shareholders.

Insider Buying and Selling at Welltower Inc.

CEO Shankh Mitra sold 3,852 shares on June 26, 2026, and bought 17 shares at an average price of $173.32 on May 31, 2026. Dennis Lopez purchased 63 shares at $216.01 on May 21, 2026. Kenneth Bacon was involved in buying 2,627 shares on May 1, 2026.

Analysts Set New Price Targets

On July 1, 2026, Evercore ISI Group maintained its buy rating with a $236 target. Previously, on June 18, 2026, Scotiabank also maintained a buy rating with a $232 target. Raymond James reinstated its buy rating with a $226 target on June 17, 2026. Overall, the consensus recommendation remains a buy, with a mean price target of $235.48 based on 21 analyst opinions.

About Welltower Inc.

Welltower Inc. is a leading real estate investment trust (REIT) focusing on healthcare facilities. Based in Toledo, Ohio, the company operates over 2,500 senior living and wellness communities across the U.S., U.K., and Canada. Under the leadership of CEO Shankh S. Mitra, Welltower's portfolio is strategically located in attractive markets, offering vibrant housing solutions for seniors. The company employs around 712 people and aims to deliver long-term growth through disciplined capital allocation and innovative partnerships.

Bottom Line

Welltower Inc. continues to attract positive attention from analysts, with Evercore ISI's reaffirmation of a buy rating highlighting strong market confidence. Shares remain near their 52-week high, reflecting robust interest in the healthcare REIT sector. As a reminder, analyst ratings and targets are forward-looking and subject to change.